Autoinjector + Maridebart Cafraglutide for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Oct 2026: Trial registered, NCT07871409
  2. 15 Oct 2026: Trial started, NCT07871409

The trials

NCT07871409: Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

State
Under way
Phase
Phase 3
People
230 planned
Started
15 Oct 2026
Primary completion
16 Jun 2027
Arms
Maridebart cafraglutide
Results
None posted
  1. 13 Oct 2026: Trial registered
  2. 15 Oct 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.